Last reviewed · How we verify

NCT04834596: OOPS

Detection and Automatic Segmentation of Liver Nodules in Patients With Colorectal Adenocarcinoma

Status unknown Last updated 8 April 2021
What this trial tests

trial testing retrospectives analysis on hepatic scanner in Detection of Liver Metastases in 300 participants. Status unknown.

Timeline
2 May 2021
Primary endpoint
1 December 2021
2 May 2022

Quick facts

Lead sponsorUniversity Hospital, Angers
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date2 May 2021
Primary completion1 December 2021
Estimated completion2 May 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Angers

Who can join

18 and older, any sex, with Detection of Liver Metastases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the diagnostic performance of artificial intelligence-based software for the detection of liver nodules on scanner in patients at risk of liver metastases of colorectal cancer

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Angers trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04834596.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing